Regulations.gov document
Determination That NOROXIN (Norfloxacin) Tablets, 400 Milligrams, Was Not Withdrawn From…
Notice · FDA-2017-P-2659 · posted Dec 12, 2017
Key facts
| Document ID | FDA-2017-P-2659-0006 |
|---|---|
| Title | Determination That NOROXIN (Norfloxacin) Tablets, 400 Milligrams, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness |
| Document type | Notice |
| Subtype | Determinations |
| Agency | FDA |
| Docket | FDA-2017-P-2659 |
| Posted | Dec 12, 2017 |
| Federal Register citation | 82 FR 58421 |
| FR document number | 2017-26693 |
| Comment period opens | Dec 12, 2017 |
| Effective date | Dec 12, 2017 |
At a glance
- 1–9 Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: